Back to Rankings

NBTX

NanobiotixD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
NBTX vs peer average
38/100
NBTX vs. peer average (D vs. C)
Grade spread
B 2 · C 4 · D 2 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

NVS is the first available peer comparator.

Major global pharma with oncology franchises — useful for framing potential commercial execution scenarios.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerNVSNovartis
NBTX
Nanobiotix
NVS
Novartis
Grade
D
C
Momentum
95
49
Value
41
65
Sentiment
7
50
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed

Grade position vs NVS

NBTX / NVS
Grade Position
Below peers
NBTX vs. peer average (D vs. C)
38/100
Momentum
95
NBTX
Value
41
NVS
Sentiment
7
NVS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NBTX
1
NVS
NVS
C
60/100
-1
2
NTLA
Intellia Therapeutics Inc Common
D
40/100
Even
3
IOVA
Iovance Biotherapeutics Inc Common
B
80/100
-2
4
OCUL
Ocular Therapeutix Inc Common
C
60/100
-1
5
LKFT
Lakefront Biotherapeutics ADR
F
20/100
+1
NVS is the first peer returned for this comparison set.